DOI:

How to become an Andreas Grüntzig in the 21st century

How to become an Andreas Grüntzig in the 21 century

Bernhard Meier

The contributions of Andreas Grüntzig to modern medicine are huge, though it may be argued that serendipity accounted for a significant part of his success. He came to Zürich to be a disciple of Robert Hegglin, an internist. Hegglin died shortly after Grüntzig’s arrival, obliging him to find a substitute tutor in the person of Alfred Bollinger, an angiologist, whose diagnostic skills he quickly acquired.

As a step still further, Grüntzig then became intrigued by the fact that unblocking arteries appeared to be conceptually simple. Charles Dotter had already shown how to dilate peripheral arteries with incremental catheters and Dotter must have given balloons a thought. However, it was Grüntzig who happened to run into a plastics expert who knew how to make a functioning dilatation balloon. Grüntzig appeared to be in danger of jeopardising the sovereignty of cardiac surgery and yet it just so happened that Åke Senning was the local chief surgeon. Senning already enjoyed considerable personal fame and was happy to share the limelight with this young cardiologist in the ascendant who was threatening to eclipse him. Lastly, Grüntzig’s first case just happened to be as good as they come – almost forty years on, his first patient has never needed bypass surgery!

While such a constellation was unlikely at the time, it would be unthinkable today. Critics would stop a Grüntzig of our times, raising ethical and regulatory red flags. His story could not be reconciled with today’s evidence-based medicine and research rigour. Yet, creative minds continue to exist and, to help them make their dreams come true, specialists have emerged alongside ever more restrictive regulations. Medical breakthroughs are still possible and young physicians must continue to strive for them. They can no longer be accomplished by a single person but the required algorithms and the money still exist. The secret is to think out of the box but not act out of the box. Casey Kasem knew it all along when he proclaimed, “Keep reaching for the stars but keep your feet on the ground”.

Bernhard Meier, MD

Professor of Cardiology, University Hospital of Bern, Bern, Switzerland

[email protected]

NEWS

EAPCI General Assembly Thursday 18 May, 10:30-12:00, Room 343! Join us and and learn about the latest developments of our Association. EAPCI Voting members will be invited to vote on a proposal for a new mission for the Association. Be there! We look forward to seeing you...

Don’t miss the free EAPCI webinar on 23 June, from 18:00 to 19:00 CET.

Join Dr R. Byrne, Professors M. Roffi and A. Baumbach for a “Focus on bleeding management strategy in patients under oral anticoagulation after PCI – from randomized clinical trials to the individual patient”.

Register online: www.escardio.org/EAPCI - Education section

Keep up to date about all the exciting upcoming European Society of Cardiology (ESC) webinars at www.escardio.org - Education section

Volume 13 Number 1
May 15, 2017
Volume 13 Number 1
View full issue

Suggested by Cory

Research Correspondence

10.4244/EIJ-D-25-00068 Jul 21, 2025
Intracoronary nicardipine to induce hyperaemia
Viscusi M et al

Editorial

10.4244/EIJ-E-25-00023 Jul 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T and Cayla G
free

Research Correspondence

10.4244/EIJ-D-25-00025 Jul 21, 2025
Validation of the pullback pressure gradient in resting conditions
Sakai K et al

Viewpoint

10.4244/EIJ-D-24-00943 Jul 21, 2025
Factor XI inhibition for ACS patients: premises and prospects
Lopes R and Fanaroff A
free

Editorial

10.4244/EIJ-E-25-00031 Jul 21, 2025
Supersaturated oxygen therapy to reduce myocardial infarct size: time to pay attention!
Stone G and Akinmolayemi O
free

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
Trending articles
224.25

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.65

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.3

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47.5

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
47.5

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved